Correspondence 0001104659-24-032476 from Praxis Precision Medicines, Inc. (PRAX) (CIK 0001689548) (PRAX)
Praxis Precision Medicines, Inc. (PRAX) (CIK 0001689548)
Date: March 8, 2024 · CIK: 0001689548 · Accession: 0001104659-24-032476
AI Filing Summary & Sentiment
File numbers found in text: 333-277656
Letter
PRAXIS PRECISION MEDICINES, INC.
99 High Street, 30th Floor
Boston, MA 02110
March 8, 2024
Via EDGAR Transmission
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attention: Jessica Dickerson
Re: Praxis Precision Medicines, Inc.
Registration Statement on Form S-3
Filed March 5, 2024
File No. 333-277656
To the addressee set forth above:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Praxis Precision Medicines, Inc. (the “Company”) hereby respectfully requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-277656, the “Registration Statement”) be accelerated by the Securities and Exchange Commission to 4:00 p.m., Eastern Time, on March 12, 2024, or at such later time as the Company or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Jennifer A. Yoon at (617) 880-4540.
If you have any questions regarding the foregoing, please do not hesitate to contact Jennifer A. Yoon of Latham & Watkins LLP at (617) 880-4540. Thank you in advance for your consideration.
Very truly yours,
Praxis Precision Medicines, Inc.
Show Raw Text
CORRESP
1
filename1.htm
PRAXIS PRECISION MEDICINES, INC.
99 High Street, 30th Floor
Boston, MA 02110
March 8, 2024
Via EDGAR Transmission
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, DC 20549
Attention: Jessica Dickerson
Re:
Praxis Precision Medicines, Inc.
Registration Statement on Form S-3
Filed March 5, 2024
File No. 333-277656
To the addressee set forth above:
Pursuant to Rule 461(a) under the Securities Act
of 1933, as amended, Praxis Precision Medicines, Inc. (the “Company”) hereby respectfully requests that the
effective date of the Company’s Registration Statement on Form S-3 (File No. 333-277656, the “Registration Statement”)
be accelerated by the Securities and Exchange Commission to 4:00 p.m., Eastern Time, on March 12, 2024, or at such later time as the Company
or its counsel may orally request via telephone call to the staff. Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel, Latham & Watkins LLP, by calling Jennifer A. Yoon at (617) 880-4540.
If you have any questions regarding the foregoing,
please do not hesitate to contact Jennifer A. Yoon of Latham & Watkins LLP at (617) 880-4540. Thank you in advance for your consideration.
Very truly yours,
Praxis Precision Medicines, Inc.
By:
/s/ Marcio Souza
Name:
Marcio Souza
Title:
Chief Executive Officer
cc:
Alex
Nemiroff, Praxis Precision Medicines, Inc.
Jennifer A. Yoon, Latham & Watkins LLP